Next-Generation Onco-Therapeutics

Nyhet

Häftad, Engelska, 2026

2 389 kr

Kommande

Next-Generation Onco-Therapeutics explores the latest advancements in cancer treatment, focusing on personalized medicine and innovative therapeutic strategies. The book serves as a comprehensive resource for understanding how emerging technologies can reshape oncological care, providing insights into effective and compassionate patient management. Content explores cutting-edge developments in cancer therapies, featuring clinical examples and case studies that illustrate the practical application of new treatment modalities. It emphasizes the importance of integrative approaches that address the diverse needs of cancer patients, ensuring that healthcare professionals are equipped with the most current information in this rapidly evolving field.

This book also addresses the urgent need for updated resources in oncological therapeutics, bridging the gap between traditional practices and modern innovations. By synthesizing diverse perspectives and evidence-based insights, it empowers healthcare providers, researchers, and policymakers to enhance treatment outcomes and improve patient well-being in the era of personalized medicine.

Provides comprehensive coverage on the latest advancements in cancer treatment, ensuring that healthcare professionals stay informed about innovative therapies and techniques
Includes clinical examples and case studies that illustrate how new treatment modalities are effectively applied in real-world settings, thus enhancing understanding and implementation
Emphasizes integrative and personalized medicine approaches that cater to the diverse needs and preferences of cancer patients

Produktinformation

Utgivningsdatum2026-06-01
Mått191 x 235 x undefined mm
Vikt450 g
FormatHäftad
SpråkEngelska
Antal sidor330
FörlagElsevier Science
ISBN9780443441813

Tillhör följande kategorier

Onkologi inom Medicin
Behandling och behandlingsmetoder inom Medicin

Dr. Awanish Kumar is an Associate Professor of the Department of Biotechnology at the National Institute of Technology, Raipur, Chhattisgarh, India. He has more than 13 years of research experience. He received his PhD in molecular parasitology from the CSIR-Central Drug Research Institute, Lucknow, India, and Jawaharlal Nehru University, Delhi, India, and completed his postdoctoral studies at McGill University, Montreal, Canada. His research interests are infection biology, drug targeting, and drug discovery. Dr. Banashree Bondhopadhyay is an Assistant Professor at the Centre for Medical Biotechnology, Amity University Uttar Pradesh, Noida, India. She earned her Ph.D. from The University of Burdwan and completed her post-doctoral fellowship at ICMR-NICPR. Her research focuses on molecular biology, molecular oncology, and healthcare, particularly breast cancer and hybrid anti-cancer natural products. Dr. Bondhopadhyay has an h-index of 14, with over 17 publications in SCI journals and has received the ICMR-DHR Women Scientist Fellowship. Her work is published in renowned journals like Biosensors and Bioelectronics and Cancers. She has received the Shri K.N. Narasimhiah Award and the Best Oral Presenter Award at Oncology Conundrums 2024. Actively involved in scientific societies, she also reviews for prestigious journals and teaches various biotechnology courses while supervising undergraduate and postgraduate students.

1. Introduction to Next-Generation Onco-Therapeutics and Evolution of Cancer Therapy2. Understanding Cancer Treatment through Immunotherapy Innovations3. Targeted Therapy Advancements in Tumor Biology4. Precision Medicine in Oncology Treatments5. Psychosocial Support and Dietary Regulations in Cancer Care6. Integrative Therapies and Combination Approaches for Synergistic Cancer Therapeutics7. The Importance of Early Detection and Screening in Cancer Treatment8. Patient-Centered Care for Cancer Therapeutics9. Advances in Cancer Drug Discovery Integrated with Computational Approaches10. Technological Advances in Onco-Therapeutics11. Ethics and Accessibility in Next-Generation Cancer Therapies12. Case Studies and Future Prospects of Next-Generation Onco-Therapeutics